Out of the validated genes, we are specifically interested in HECT-domain type E3 ligase NEDD4L, since the altered expression of this gene has been shown to affect cancer progression in a wide range of cancer types including breast cancer, glioma, non-small cell lung cancer and prostate cancer (24–31). This evidence concerns the gene NEDD4L and prostate carcinoma.